Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ADO-TRASTUZUMAB EMTANSINE Cause Insomnia? 112 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 112 reports of Insomnia have been filed in association with ADO-TRASTUZUMAB EMTANSINE. This represents 1.3% of all adverse event reports for ADO-TRASTUZUMAB EMTANSINE.

112
Reports of Insomnia with ADO-TRASTUZUMAB EMTANSINE
1.3%
of all ADO-TRASTUZUMAB EMTANSINE reports
28
Deaths
52
Hospitalizations

How Dangerous Is Insomnia From ADO-TRASTUZUMAB EMTANSINE?

Of the 112 reports, 28 (25.0%) resulted in death, 52 (46.4%) required hospitalization, and 4 (3.6%) were considered life-threatening.

Is Insomnia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ADO-TRASTUZUMAB EMTANSINE. However, 112 reports have been filed with the FAERS database.

What Other Side Effects Does ADO-TRASTUZUMAB EMTANSINE Cause?

Nausea (780) Fatigue (774) Disease progression (750) Diarrhoea (654) Off label use (630) Thrombocytopenia (519) Death (509) Neuropathy peripheral (506) Headache (465) Platelet count decreased (453)

What Other Drugs Cause Insomnia?

ADALIMUMAB (6,888) DULOXETINE (5,270) ETANERCEPT (4,983) PREGABALIN (4,882) METHOTREXATE (4,757) LEVOTHYROXINE (4,663) TOCILIZUMAB (4,001) PREDNISONE (3,804) LENALIDOMIDE (3,651) RITUXIMAB (3,637)

Which ADO-TRASTUZUMAB EMTANSINE Alternatives Have Lower Insomnia Risk?

ADO-TRASTUZUMAB EMTANSINE vs ADRIAMYCIN ADO-TRASTUZUMAB EMTANSINE vs ADUCANUMAB ADO-TRASTUZUMAB EMTANSINE vs ADUCANUMAB-AVWA ADO-TRASTUZUMAB EMTANSINE vs ADVAIR ADO-TRASTUZUMAB EMTANSINE vs ADVAIR HFA

Related Pages

ADO-TRASTUZUMAB EMTANSINE Full Profile All Insomnia Reports All Drugs Causing Insomnia ADO-TRASTUZUMAB EMTANSINE Demographics